ZV

Zhongnuo Venture Capital

Description

Zhongnuo Venture Capital is an investment Firm.

Investor Profile

Zhongnuo Venture Capital has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (50%)
  • Series A (50%)

Country Focus

  • United States (50%)
  • China (50%)

Industry Focus

  • Medical
  • Biotechnology
  • Therapeutics
  • 3d Printing
  • Health Care
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Zhongnuo Venture Capital frequently co-invest with?

Puhua Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
SNÖ Ventures
Europe, Oslo, Norway, Oslo
Co-Investments: 1
Co-Investments: 1
Co-Investments: 1
Galaxy Capital
Asia, Jiangsu, China, Suzhou
Co-Investments: 1
Morningside Venture Investments
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Evonik Venture Capital
Europe, Hessen, Germany, Hanau
Co-Investments: 1
Yanchuang Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
ShenZhen GTJA Investment Group
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Oriza Holdings
Asia, Jiangsu, China, Suzhou
Co-Investments: 1

What are some of recent deals done by Zhongnuo Venture Capital?

TenNor Therapeutics

Westfield, New Jersey, United States

TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases

BiotechnologyMedicalTherapeutics
Series DMar 30, 2022
Amount Raised: $41,589,867
Medvance

Shanghai, Shanghai, China

Medvance is a medical 3D printing technology company.

3D PrintingHealth CareManufacturingMedical
Series ASep 6, 2019